Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free MDNA Stock Alerts

Medicenna Therapeutics (MDNA) Competitors

Medicenna Therapeutics logo
C$0.36 0.00 (0.00%)
As of 07/31/2026 04:00 PM Eastern
Compare

MDNA vs. GXE, CGC, WMD, EQ, and SGW

Should you buy Medicenna Therapeutics stock or one of its competitors? MarketBeat compares Medicenna Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Medicenna Therapeutics include Gear Energy (GXE), Canadian Gold (CGC), WeedMD (WMD), EQ (EQ), and Shoal Games (SGW).

How does Medicenna Therapeutics compare to Gear Energy?

Gear Energy (TSE:GXE) and Medicenna Therapeutics (TSE:MDNA) are related small-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

In the previous week, Gear Energy's average media sentiment score of 0.00 equaled Medicenna Therapeutics'average media sentiment score.

Company Overall Sentiment
Gear Energy Neutral
Medicenna Therapeutics Neutral

2.4% of Gear Energy shares are held by institutional investors. Comparatively, 0.4% of Medicenna Therapeutics shares are held by institutional investors. 7.6% of Gear Energy shares are held by company insiders. Comparatively, 22.6% of Medicenna Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Gear Energy has a beta of 3.52, meaning that its stock price is 252% more volatile than the broader market. Comparatively, Medicenna Therapeutics has a beta of 2.960355, meaning that its stock price is 196% more volatile than the broader market.

Gear Energy has higher revenue and earnings than Medicenna Therapeutics. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than Gear Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gear EnergyC$134.93M0.00C$13.02MC$0.05N/A
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.22N/A

Gear Energy has a net margin of 5.77% compared to Medicenna Therapeutics' net margin of -533,640.00%. Gear Energy's return on equity of 3.52% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Gear Energy5.77% 3.52% 4.84%
Medicenna Therapeutics -533,640.00%-219.30%-32.80%

Summary

Gear Energy beats Medicenna Therapeutics on 9 of the 10 factors compared between the two stocks.

How does Medicenna Therapeutics compare to Canadian Gold?

Canadian Gold (CVE:CGC) and Medicenna Therapeutics (TSE:MDNA) are related small-cap companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

0.3% of Canadian Gold shares are held by institutional investors. Comparatively, 0.4% of Medicenna Therapeutics shares are held by institutional investors. 43.3% of Canadian Gold shares are held by company insiders. Comparatively, 22.6% of Medicenna Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Canadian Gold is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canadian GoldN/AN/A-C$3.62M-C$0.02N/A
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.22N/A

Canadian Gold has a beta of -1.586234, meaning that its stock price is 259% less volatile than the broader market. Comparatively, Medicenna Therapeutics has a beta of 2.960355, meaning that its stock price is 196% more volatile than the broader market.

In the previous week, Canadian Gold's average media sentiment score of 0.00 equaled Medicenna Therapeutics'average media sentiment score.

Company Overall Sentiment
Canadian Gold Neutral
Medicenna Therapeutics Neutral

Canadian Gold has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. Canadian Gold's return on equity of -92.98% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Canadian GoldN/A -92.98% -48.06%
Medicenna Therapeutics -533,640.00%-219.30%-32.80%

Summary

Canadian Gold beats Medicenna Therapeutics on 5 of the 9 factors compared between the two stocks.

How does Medicenna Therapeutics compare to WeedMD?

WeedMD (CVE:WMD) and Medicenna Therapeutics (TSE:MDNA) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

WeedMD has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. WeedMD's return on equity of 0.00% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
WeedMDN/A N/A N/A
Medicenna Therapeutics -533,640.00%-219.30%-32.80%

Medicenna Therapeutics has lower revenue, but higher earnings than WeedMD. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than WeedMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WeedMDC$27.53M2.46-C$102.60M-C$0.42N/A
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.22N/A

0.4% of Medicenna Therapeutics shares are owned by institutional investors. 22.6% of Medicenna Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, WeedMD's average media sentiment score of 0.00 equaled Medicenna Therapeutics'average media sentiment score.

Company Overall Sentiment
WeedMD Neutral
Medicenna Therapeutics Neutral

Summary

WeedMD beats Medicenna Therapeutics on 5 of the 9 factors compared between the two stocks.

How does Medicenna Therapeutics compare to EQ?

Medicenna Therapeutics (TSE:MDNA) and EQ (CVE:EQ) are related small-cap companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

EQ has a net margin of -11.73% compared to Medicenna Therapeutics' net margin of -533,640.00%. EQ's return on equity of 50.96% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Medicenna Therapeutics-533,640.00% -219.30% -32.80%
EQ -11.73%50.96%-18.43%

EQ has higher revenue and earnings than Medicenna Therapeutics. EQ is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.22N/A
EQC$10.54M6.34-C$4.66M-C$0.02N/A

In the previous week, EQ had 1 more articles in the media than Medicenna Therapeutics. MarketBeat recorded 1 mentions for EQ and 0 mentions for Medicenna Therapeutics. EQ's average media sentiment score of 0.53 beat Medicenna Therapeutics' score of 0.00 indicating that EQ is being referred to more favorably in the news media.

Company Overall Sentiment
Medicenna Therapeutics Neutral
EQ Positive

Medicenna Therapeutics has a beta of 2.960355, suggesting that its stock price is 196% more volatile than the broader market. Comparatively, EQ has a beta of -0.011235, suggesting that its stock price is 101% less volatile than the broader market.

0.4% of Medicenna Therapeutics shares are held by institutional investors. Comparatively, 0.1% of EQ shares are held by institutional investors. 22.6% of Medicenna Therapeutics shares are held by company insiders. Comparatively, 12.8% of EQ shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

EQ beats Medicenna Therapeutics on 8 of the 12 factors compared between the two stocks.

How does Medicenna Therapeutics compare to Shoal Games?

Medicenna Therapeutics (TSE:MDNA) and Shoal Games (CVE:SGW) are related small-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

0.4% of Medicenna Therapeutics shares are held by institutional investors. 22.6% of Medicenna Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Shoal Games has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. Shoal Games' return on equity of 0.00% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Medicenna Therapeutics-533,640.00% -219.30% -32.80%
Shoal Games N/A N/A N/A

Shoal Games has higher revenue and earnings than Medicenna Therapeutics. Shoal Games is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.22N/A
Shoal GamesC$106.98K612.86-C$5.25M-C$0.04N/A

In the previous week, Medicenna Therapeutics' average media sentiment score of 0.00 equaled Shoal Games'average media sentiment score.

Company Overall Sentiment
Medicenna Therapeutics Neutral
Shoal Games Neutral

Summary

Shoal Games beats Medicenna Therapeutics on 6 of the 9 factors compared between the two stocks.

Get Medicenna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDNA vs. The Competition

Export
MetricMedicenna TherapeuticsBiotechnology IndustryHealthcare SectorTSE Exchange
Market CapC$33.23MC$3.54BC$6.85BC$12.25B
Dividend YieldN/A3.78%2.59%6.20%
P/E Ratio-1.647.38282.2833.59
Price / SalesN/A1,199.83563.219.16
Price / Cash1.1544.8028.6082.29
Price / Book12.1016.9610.964.33
Net Income-C$25.98M-C$12.56MC$3.49BC$299.09M
7 Day Performance4.35%-1.80%-0.63%-0.53%
1 Month Performance-8.86%-8.44%-5.23%-1.72%
1 Year Performance-57.14%48.63%62.07%32.66%

Medicenna Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDNA
Medicenna Therapeutics
N/AC$0.36
flat		N/A-57.1%C$33.23MN/AN/A20
GXE
Gear Energy
N/AN/AN/AN/AC$126.52MC$134.93M10.391,310
CGC
Canadian Gold
N/AC$0.60
-6.3%		N/A+103.4%C$126.35MN/AN/A3,150
WMD
WeedMD
N/AC$0.28
-1.8%		N/A+0.0%C$67.82MC$27.53MN/A628
EQ
EQ
N/AC$0.97
flat		N/A-1.0%C$67.51MC$10.54MN/A40

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:MDNA) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel